Group items tagged

Si vous recherchez un programme complet et détaillé de remise en forme et de nutrition qui vous aidera à perdre votre graisse corporelle non désirée (en particulier vers le milieu du corps), ce programme ... http://tinyurl.com/brulerdelagraisse

Découvrez l'ingrédient le plus essentiel pour gagner du muscle, sans lequel vous n'obtiendrez aucun résultat. Plus important que l'entraînement, que l'alimentation, que les compléments alimentaires et même que les stéroïdes anabolisants ! L'élément sans lequel vous n'avez aucune chance de vous forger un corps parfait !

Thanks to the investments we made in the Affordable Care Act and the Recovery Act, the numbers of doctors, nurses, and health care professionals in this program has nearly tripled in the last three years.

Boehringer Ingelheim UK & Ireland has appointed Vani Manja as its new Country Managing Director and Head of Human Pharma. Manja has been associated with Boehringer Ingelheim for over 11 years, in successful leadership roles in Germany, the United States and most recently as General Manager, India. Her career started as a commissioned officer in the Indian Army Ordnance Corps which preceded leadership roles at Becton Dickinson and McKinsey. She brings extensive experience of strategy, marketing, sales, business development, people management, and cultural transformation and is passionate about tackling healthcare inequalities and advancing sustainable healthcare. Commenting on her new role, Manja said: "It is with great heart that I bring the spirit of conscious leadership to my new role. I look forward to being fully present and partnering with key stakeholders in the healthcare ecosystem in our collective quest to improve health for humans and animals in the UK and Ireland."

The Royal Pharmaceutical Society (RPS) announced three new awards - the Daniel Thomas Award, the OPERA Award and the Barnett Award - at its annual conference on Friday. RPS President Professor Claire Anderson said each award recognises "exceptional contributions to the pharmacy field." The Daniel Thomas Award recognises pharmacists or pharmaceutical scientists who died while actively practising in the profession. It is named after Daniel Thomas, a pharmacist who died during the First World War in 1917 while serving with the Royal Army Medical Corps. The Outstanding Pharmacy Early-Career Researcher Award or OPERA Award recognises the achievements of early-career researchers within the pharmacy field.

Chiesi Farmaceutici, the international, research-focused biopharmaceuticals and healthcare group has acquired Amryt Pharma, a global biopharmaceutical company dedicated to developing novel treatments for rare diseases. More than 300 million people worldwide are affected by rare diseases, including those who are living with ultra-rare metabolic and dermatologic conditions who still have no approved treatment. The acquisition reinforces Chiesi's commitment to deliver innovative treatments to patients with highly unmet medical needs. As a benefit corporation and a B Corp, Chiesi strives to create a world where it is common to have a therapy for all diseases and acts as a force for good, for society and the planet. Chiesi's Head of Chiesi Global Rare diseases Giacomo Chiesi commented: "We are excited to add the Amryt family to our company in this acquisition that demonstrates our commitment to rare diseases and aligns with our growth strategy through partnerships beyond internal research and development." Chiesi's new CEO Giuseppe Accogli said: "By joining forces and expertise we will be able to grow our capabilities and further strengthen our position to provide a positive impact on patients living with rare diseases." With regard to the financing of the deal, cash consideration has been partially financed through a EUR 700m syndicated loan led by BNP Paribas and Crédit Agricole as Global Coordinators and ESG Structuring Banks, acting alongside BPER and Deutsche Bank as Mandated Lead Arrangers. Crédit Agricole is Loan Agent too. Lenders have been advised by Clifford Chance, while Baker and McKenzie has assisted Chiesi Farmaceutici.

Beaucoup d'infections de candidose vaginale peuvent en fait être provoquées par les vêtements que vous portez, spécifiquement vos sous-vêtements. La candida se développent particulièrement très bien dans un environnement qui n'est pas en coton et qui est serré ou sali. Les matériaux artificiels emprisonnent la chaleur et l'humidité qui crée la culture parfaite pour multiplier une infection de candidose. Regardez ces images de femmes d'Amazone dans leurs sous-vêtements en cuir. Elles doivent avoir eu des infections de candidose tout le temps.